Abvc Biopharma (ABVC) Research & Development (2015 - 2026)
Abvc Biopharma's Research & Development came in at $22,707 for Q2 2026, down 31.8% from $33,276 a year earlier and down 31.4% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Research & Development (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Abvc Biopharma reported Research & Development of $114,755, down 13.0% year-over-year; for FY2025, it came in at $121,085, down 32.5% from FY2024.
- Research & Development has declined in each of the last three years, with a five-year compound annual growth rate of -26.1% (FY2020 to FY2025).
- Going back by year, Research & Development was $179,272 in FY2024 (-83.1%), $1.06 million in FY2023 (-60.5%), $2.69 million in FY2022 (+168.3%) and $1 million in FY2021 (+82.6%).
- The Q2 2026 figure represents the lowest quarterly Research & Development in data going back to Q1 2016.
- Year-over-year, Research & Development increased in 1 of the last eight quarters, with an average decline of 31.5%.
- The fastest year-over-year change in Research & Development over five years came in Q4 2022 (growth of 474.9%), and the weakest in Q4 2023 (a decline of 95.2%).
- Business Quant data shows ABVC's Research & Development at $33,100 (Q1 2026), $29,058 (Q4 2025) and $29,890 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - | 22,707.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22,707.00 |
| Mar 31, 2026 | 33,100.00 |
| Dec 31, 2025 | 29,058.00 |
| Sep 30, 2025 | 29,890.00 |
| Jun 30, 2025 | 33,276.00 |
| Mar 31, 2025 | 28,861.00 |
| Dec 31, 2024 | 31,980.00 |
| Sep 30, 2024 | 37,825.00 |
| Jun 30, 2024 | 40,401.00 |
| Mar 31, 2024 | 69,066.00 |
| Dec 31, 2023 | 72,185.00 |
| Sep 30, 2023 | 141,310.00 |
| Jun 30, 2023 | 514,442.00 |
| Mar 31, 2023 | 334,979.00 |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | 305,483.00 |
| Jun 30, 2022 | 532,782.00 |
| Mar 31, 2022 | 359,404.00 |
| Dec 31, 2021 | 260,188.00 |
| Sep 30, 2021 | 263,424.00 |
API Access
Abvc Biopharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();